Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00628433 · ClinicalTrials.gov registry record · Phase 1

Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis

A Phase 1 study of Ulcerative Colitis, sponsored by Harbor Therapeutics.

Completed
Registry status
Phase 1
Development phase
27
Enrollment target
10
Study locations

NCT00628433 is a Phase 1 study of Ulcerative Colitis that has completed, run by Harbor Therapeutics. The registered enrollment target is 27 participants, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (99% lower). The trial reports 10 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00628433, a Phase 1 study of Ulcerative Colitis, has completed, sponsored by Harbor Therapeutics.

COMPLETED
Registry status
Phase 1
Development phase
27 participants
Enrollment target
10
Study locations

Study Summary

The purpose of this pilot, exploratory study is to evaluate the safety, tolerance, pharmacokinetics and potential activity of an investigational agent, HE3286, when administered orally, daily for 28 days to patients with mild-to-moderate ulcerative colitis.

Conditions Studied

Ulcerative Colitis

Interventions

  • DRUG Placebo
  • DRUG HE3286

Study Locations (10)

California

  • - Anaheim
  • - Fresno
  • - La Jolla

Colorado

  • - Denver
  • - Denver

Arizona

  • - Tucson

Florida

  • - Winter Park

Georgia

  • - Atlanta

Kentucky

  • - Louisville

Texas

  • - El Paso

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2008-02
Est. Completion 2009-05
Phase Phase 1

Sponsor

Harbor Therapeutics

7 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00628433

The ClinicalTrials.gov registry entry for NCT00628433 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (99% lower). The listed sponsor is Harbor Therapeutics, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ulcerative Colitis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00628433 reports 10 study locations spanning 7 distinct geographic areas - top geographies include California, Colorado, Arizona.

Frequently Asked Questions

What is clinical trial NCT00628433 about?

NCT00628433 is a clinical study titled "Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis". The purpose of this pilot, exploratory study is to evaluate the safety, tolerance, pharmacokinetics and potential activity of an investigational agent, HE3286, when administered orally, daily for 28 days to patients with mild-to-moderate ulcerative colitis.

What is the current status of trial NCT00628433?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2008-02. Estimated completion is 2009-05.

What conditions does trial NCT00628433 study?

This clinical trial studies the following conditions: Ulcerative Colitis.

What interventions are being tested in trial NCT00628433?

The interventions under investigation include: Placebo (DRUG), HE3286 (DRUG).

Who is sponsoring clinical trial NCT00628433?

This trial is sponsored by Harbor Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00628433 being conducted?

This trial has 10 study locations across Arizona, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ulcerative Colitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ulcerative Colitis

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.